INTRODUCTION
Biomolecular strategies for therapeutic intervention in cancer Oncogene (2003 Oncogene ( ) 22, 6469. doi:10.1038 Since its inception, we have designed this issue of Oncogene Reviews to represent a sort of interdisciplinary experiment aimed to prompt the scientific community and ourselves to perceive cancer treatment under a novel and more comprehensive light.
In fact, we are steadily improving our understanding of distinct aspects of the extremely complex and highly heterogeneous biomolecular mechanisms governing cancer development and progression. This swift advance allows us to design and to apply in the clinic new therapeutic strategies to counteract specific defects and/ or to take advantage of peculiar biological and molecular features of neoplastic cells. These new and ever more patient-tailored clinical approaches encompass multiple disciplines spanning from molecular and cellular biology to immunology and pharmacology. Therefore, through the analysis of scientific achievements concerning specific topics pertinent to distinct areas of cancer biology, in this issue of Oncogene Reviews we attempt to highlight some of the most innovative and promising therapeutic options presently available, or in their final stages of preclinical development, for cancer patients.
Nevertheless, although no one denies that vigorous research efforts must continue in different disciplines of cancer biology to define more effective strategies of prevention, diagnosis and treatment, it might be necessary to re-evaluate how cancer is perceived by the scientific community, not only as a disease characterized by the disruption of specific biomolecular patterns on which to focus research and therapeutic intervention, but rather as a whole and highly complex biological system, with its own schemes and rules, which will require an extremely open-minded and comprehensive intellectual approach to be fully understood and eventually defeated. This being the case, we are faced with the puzzling question repeatedly asked by Professor Giovan Giacomo Giordano (ie, Antonio's father and scientific mentor and Michele's example of scientific enthusiasm): 'Is cancer like life itself? Both are phenomena that, despite tremendous scientific progress, still remain largely unknown. As such, will it be possible one day to write out their 'equations'? If so, will it be one equation or two?'.
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